Activity of Fabaceae species extracts against fungi and Leishmania: vatacarpan as a novel potent anti-Candida agent  by Santana, Dandara Braga et al.
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Leishmaniasis  and  fungal  infection  treatment  efﬁcacy  is  limited  by  toxicity  and  ever increasing  resis-
tance  to available  drugs,  requiring  development  of alternative  compounds.  The  richness  of  Cerrado  plant
antimicrobial  secondary  metabolites  justiﬁes  screening  of Fabaceae  species  extracts:  Enterolobium  ellip-
ticum  Benth.,  Sclerolobium  aureum  (Tul.) Baill.  and  Vatairea  macrocarpa  (Benth.)  Ducke,  against  Leishmania
(Leishmania)  amazonensis,  yeasts  and  dermatophytes.  Among  the  26 extracts  tested,  more  than  50%  of  the
total demonstrated  signiﬁcant  antifungal  activity  in  comparison  to the drug  controls  (minimal  inhibitory
concentration  0.12  to ≤31.25  g/ml).  Six  extracts  capable  of  complete  parasitic  growth  inhibition  had  the
inhibitory  concentration  index  for  50%  values  from  9.23  to  78.65  g/ml.  The  results  led to the  selection
of  the  V.  macrocarpa  ethyl  acetate  root  bark  extract  for  chemical  fractionation.  This  plant,  tradition-
ally  referred  to as angelim-do-cerrado  or maleiteira,  is  used  to  treat  superﬁcial  mycoses  in  Amazonia.  Aeishmania
ungi previously  unreported  pterocarpan  vatacarpan  together  with  the  known  compound  musizin  was iso-
lated.  Vatacarpan  demonstrated  a  minimal  inhibitory  concentration  value  of  0.98  g/ml  against  Candida
albicans  ATCC  10231,  and  thus  comparable  or superior  to ﬂuconazole  and  amphotericin  B.  The  results
add  to  literature’s  information  the  ability  of  pterocarpans  to  act  as  antimicrobial  agents.
ileira©  2015 Sociedade  Bras
ntroduction
Natural products and their ethnopharmacological activities
ave been historically used as a primary source of compounds for
rug discovery. However, for the last twenty years, the technical
equirements for high throughput screening led the pharmaceuti-
al industry to focus on combinatorial chemistry libraries instead.
his pathway was only partly successful since it came up with struc-
ures that lacked the complex scaffold of secondary metabolites.
urrently, natural products are again a source of drug discovery,
roviding lead compounds for clinical trials, including antimicro-
ial agents (Dias et al., 2012; Harvey et al., 2015).The incidence of fungal infections has signiﬁcantly increased
ince the late 1960s, primarily with cases of immune-compromised
r hospitalized patients. Research dedicated to the development
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of new therapeutic strategies has culminated in four antifun-
gal classes currently used in clinical practice: ﬂuoropyrimidine
analogs, polyenes (such as amphotericin B, the most commonly
used medication for systemic infections) azoles and equinocan-
dines (Vandeputte et al., 2012).
Cutaneous leishmaniasis is considered a neglected tropical
diseases group, with 1.5 million people worldwide manifesting
skin lesions which persist for several months, or even years (Silva
et al., 2013). Pentavalent antimonials (Sb+5) remain the primary
treatment option, despite their toxicity and low patient tolerance,
with either pentamidine or amphotericin B used as second line
treatments.
The failure of the aforementioned drug strategies has been
attributed to microbial resistance. The use of plants by tradi-
tional local communities and the richness of Cerrado species
antimicrobial secondary metabolites have been reported (De  Assis
et al., 2014; Albernaz et al., 2012; Melo e Silva et al., 2009; De
Mesquita et al., 2005). We screened Fabaceae extracts from the
Cerrado: Enterolobium ellipticum Benth., Sclerolobium aureum (Tul.)
Baill. and Vatairea macrocarpa (Benth.) Ducke, against Leishmania
 Ltda. All rights reserved.
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Leishmania) amazonensis, yeasts and dermatophytes. These
ntimicrobial results led to the selection of V. macrocarpa root bark
thyl acetate extract for further chemical studies. Here, we  present
he isolation, structure elucidation and antimicrobial activity of one
terocarpan. This new natural product was more active than the
ntifungal reference ﬂuconazole and amphotericin B.
aterials and methods
lant extracts
Plant species Enterolobium ellipticum Benth., Sclerolobium
ureum (Tul.) Baill. and Vatairea macrocarpa (Benth.) Ducke,
abaceae, were collected in 2010 from the Cerrado biome in the
agoa Formosa area, Planaltina, Federal District of Brazil, south lat-
tude 15◦27′34.2′′; south longitude 47◦92′3.3′′; at an altitude of
071 m,  and subsequently identiﬁed by botanist Prof. José Elias
e Paula. Voucher numbers were kept in the University of Brasilia
UB/UnB) Herbarium (Table 1). Plant organs were separated, dried,
tabilized, pulverized and extracted by maceration with hexane,
thyl acetate and ethanol. The extractive solutions were concen-
rated in a rotary evaporator, yielding different crude extracts,
hich were stored at −20 ◦C.ntifungal activity method
The minimal inhibitory concentration (MIC) of each extract was
etermined for yeasts: Candida albicans ATCC 10231, C. parapsilosis
able 1
abaceae species extract activity – determination of the minimum inhibitory concentr
eishmania (Leishmania) amazonensis.
Fabaceae family
species
Voucher number
Extract
Plant part
(solvent)/% yield
C. albicans
ATCC 10223
C. parapsilosis
ATCC 22019
Enterolobium ellipticum
Benth
(UB) 3739
RW (h)/0.37 250 250 
RW  (ea)/0.56 1.95 3.91 
RW  (e)/9.05 >1000 >1000 
RB  (ea)/1.44 500 125 
SW  (h)/0.32 >1000 1000 
SW  (ea)/0.61 0.98 31.25 
SB  (h)/0.55 1000 500 
SB  (ea)/2.18 >1000 15.62 
L  (ea)/5.64 125 15.62 
Sclerolobium aureum
(Tul.) Baill.
(UB) 3818
RW (h)/0.42 >1000 >1000 
RW  (ea)/0.62 0.48 0.12 
RW  (e)/6.06 1.95 3.91 
RB  (ea)/1.98 7.81 7.81 
SW  (h)/0.25 1000 500 
SW  (ea)/0.66 0.48 15.62 
SW  (e)/3.47 0.12 0.12 
SB  (ea)/2.05 7.81 15.62 
L  (ea)/4.74 250 7.81 
Vatairea macrocarpa
(Benth.) Ducke
(UB) 3815
RW (h)/0.48 0.98 1.95 
RW  (ea)/0.90 3.91 3.91 
RB  (ea)/9.78 0.98 0.98 
SW  (h)/0.43 250 250 
SW  (ea)/0.78 1.95 1.95 
SW  (e)/4.25 0.24 1.95 
SB  (ea)/4.84 1.95 1.95 
L  (ea)/8.58 1.95 1.95 
Itraconazole 0.125 0.0625 
Flucytosine 0.25 0.0635 
Fluconazole 1 0.5 
Amphotericin B 4 4 
lant parts – RW:  root wood, RB: root bark, SW:  stem wood, SB: stem bark, L: leaves. Solv
MGO (Laboratório de Micologia de Goiás) strains were clinical isolates from patients of tarmacognosia 25 (2015) 401–406
ATCC 22019 and C. glabrata LMGO 44, using CLSI M27-A3 and
M27-S4 protocols (CLSI, 2008a, 2012); and for dermatophytes:
Trichophyton mentagrophytes LMGO 09 and Trichophyton rubrum
LMGO 06, following the CLSI M38-A2 protocol (CLSI, 2008b);
with minor modiﬁcations as previously described by the research
group (Da Costa et al., 2014) (see Supporting information). The
LMGO (Laboratório de Micologia de Goiás) strains are clinical
isolates from patients at the Federal University of Goiás Hospital,
Brazil. Itraconazole (Sigma), ﬂucytosine (Sigma) and amphotericin
B (Sigma) were used as reference compounds for yeasts and
dermatophytes. A fourth positive control ﬂuconazole (Sigma) was
used for yeasts only.
In vitro antileishmanial activity
The extracts were tested against Leishmania (Leishmania)
amazonensis (L(L)a)(MHOM/BR/PH8) promastigotes maintained in
Schneider culture medium (Sigma) with 20% heat-inactivated fetal
calf serum, at 22–25 ◦C. Extracts were dissolved in DMSO (Sigma)
and diluted in Schneider’s medium (Sigma). The inhibitory concen-
tration index for 50% (IC50) of the promastigotes was determined
by the MTT  method. Experiments were performed as previously
described (Da Costa et al., 2014) (see Supporting information) with
amphotericin B (Sigma) used as the reference drug.General experimental procedures
Column chromatography was performed using silica gel 60
(230–400 mesh, Merck). Thin Layer Chromatography (TLC) was
ation (MIC – g/ml) against yeasts and dermatophytes, and IC50 (g/ml) against
MIC  (g/ml) IC50 (g/ml)
L. (L.) amazonensis
C. glabrata
LMGO 44
T. mentagrophytes
LMGO 09
T. rubrum
LMGO 06
125 500 250 >100
>1000 500 62.5 >100
>1000 >1000 1000 70.05
>1000 500 500 >100
500 1000 500 78.65
>1000 250 250 >100
250 500 1000 25.87
>1000 125 500 9.23
>1000 250 >1000 >100
>1000 1000 250 >100
31.25 31.25 31.25 >100
15.62 31.25 31.25 >100
15.62 15.62 31.25 >100
500 500 31.25 >100
15.62 15.62 31.25 >100
0.12 15.62 31.25 >100
7.81 15.62 31.25 >100
1000 >1000 >1000 >100
500 62.5 500 72.39
250 125 500 >100
31.25 62.5 125 71.47
>1000 1000 125 >100
500 62.5 125 >100
500 31.25 62.5 >100
250 31.25 31.25 >100
250 62.5 62.5 >100
0.125 0.25 0.125 –
0.125 – –
4 4 2 –
16 4 – 0.067
ents – h: hexane, ea: ethyl acetate, e: ethanol; –: not tested.
he Federal University of Goiás Hospital.
ra de Farmacognosia 25 (2015) 401–406 403
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Table 2
1H (300 MHz) and 13C (75 MHz) NMR  data assignments for vatacarpan (CDCl3).
Carbon
number
HSQC HMBC
ıC ıH 2JCH 3JCH
1 114.3 6.95 (s) H-11a
1a 123.2 –
2 143.7 –
3 146.6 – H-1/MeO-3
4  116.0 –
4a 147.3 – H-1/H-11a
6  70.6 4.02 (d, 10.0)
3.64 (d, 10.0)
H-11a
6a 46.7 –
7 124.4 7.01 (d, 7.9)
7a  123.9 – H-8/H-10
8  107.7 6.36 (dd, 7.9, 2.2) H-10/H-7a
9  156.8 – H-7
10 98.6 6.34 (d, 2.2)
10a 160.9 – H-7
11a 83.1 5.10 (s) H-1
1′ 26.7 3.34 (d, 6.5)
2′ 122.8 5.14 (t, 6.5) 3H-4′/3H-5′
3′ 131.0 – 3H-4′/3H-5′
4′ 18.1 1.76 (s) 3H-5′
5′ 25.9 1.66 (s) 3H-4′
1′′ 31.2 2.45 (d, 7.5) H-6
2′′ 118.9 5.23 (t, 7.8) 3H-4′′/3H-5′′
3′′ 135.6 – 3H-4′′/3H-5′′
4′′ 18.2 1.54 (s) 3H-5′′D.B. Santana et al. / Revista Brasilei
erformed on precoated silica gel aluminum plates (TLC Silica gel
0 F254, Merck). The compounds were visualized by UV detec-
ion and/or sprayed with a solution of vanillin/sulphuric acid/EtOH.
ptical rotation was measured on a Perkin Elmer 341 polarimeter.
he IR spectra (KBR pellets) were recorded using a Perkin-Elmer
T-IR 1000 spectrometer. The high resolution electrospray ioniza-
ion mass spectra (HRESIMS) were acquired using a LCMS-IT-TOF
225-07100-34) Shimadzu spectrometer. The mass spectra were
ecorded on a Shimadzu QP 5000/DI-50 spectrometer, operating
ith electron impact at 70 eV. The 1D and 2D NMR  data were
cquired on a Bruker Avance DPX-300 spectrometer, equipped with
 5 mm  multinuclear inverse probe, using gradient ﬁeld in the Z
irection and a magnitude of 10 A. Chemical shifts, given on the
 scale, were referenced to the residual undeuterated portion of
he CDCl3, deuterated solvent. All standard pulse sequences were
rovided by the Bruker TOP-SPIN software. All experiments were
onducted at room temperature.
xtraction and isolation
A 115.70 g portion of V. macrocarpa root bark was  dried,
owdered and subsequently macerated in ethyl acetate at room
emperature, yielding 11.83 g of extract after solvent evaporation
nder reduced pressure. An 8.28 g portion of the EtOAc extract was
ractionated with hexane, EtOAc and MeOH as the binary mixture
f increasing polarity and yielded 65 fractions which were analyzed
y TLC.
Flash chromatography of fractions 19–22 (749.9 mg), by elu-
ion with hexane, ethyl acetate and MeOH as a binary mixture of
ncreasing polarity yielded 316 fractions analyzed by TLC.
Fraction 3 (50–61) (5.10 mg)  corresponded to musizin (2).
Fraction 9 (176–179) (27.5 mg)  and fraction 10 (180–183)
40.3 mg)  were regrouped following TLC analysis. A new ﬂash chro-
atography was conducted which yielded 141 fractions analyzed
y TLC. Fraction 3 (16–21) (4.60 mg)  was found to be a previously
nreported pterocarpan–named herein as vatacarpan (1).
Vatacarpan (1). White solid; m.  p. 135.2–136.4 ◦C; []D = + 63◦
c. 0.1, MeOH); 1H and 13C NMR  (CDCl3, 300 MHz) see Table 2; HR-
SI-TOFMS (1) m/z  423.2166 [M+H]+ (calcd for C26H30O5).
Musizin (2). Brown crystals, 1H (CDCl3, 300 MHz): 6.99 (s, H-4),
.08 (d, 7.8, H-5), 7.48 (t, 7.8, H-6), 6.84 (d, 7.8, H-7), 2.76 (s, H-12),
.66 (s, H-13), 17.35 (s, OH-1), 10.24 (s, OH-8) and 13C NMR: 205.2
C-11), 168.8 (C-1), 158.8 (C-8), 138.4 (C-10), 133.0 (C-6), 132.4 (C-
), 122.1 (C-4), 117.7 (C-5), 113.8 (C-2), 113.2 (C-9), 111.4 (C-7),
2.4 (C-12), 25.5 (C-13).
2'
2''
3'
3''
4''
4'5'
5''
1'
4 4a
1a
11a
10a
8
7
7
6
5 4
10 3
9
8 1
11
2 12
13
6
7a
6a
3
2
1
1''
HO
H3CO
OH OH O
O
O
210 9 OH1
esults and discussion
A total of 26 extracts were prepared from the Fabaceae fam-
ly: nine from E. ellipticum,  nine from S. aureum, and eight from
. macrocarpa. Of all the extracts, 85% presented activity against
 minimum of one fungal strain using the active extract criterion
MIC ≤125 g/ml) speciﬁed by Albernaz et al. (2010). In addition,5′′ 26.2 1.70 (s) 3H-4′′
MeO-5 61.7 3.79 (s)
more than 50% of the total samples demonstrated signiﬁcant activ-
ity in comparison to the drug controls (MIC 0.12 to ≤31.25 g/ml)
(Table 1). The inhibitory concentration index for 50% of the pro-
mastigotes from L. (L.) amazonensis (IC50 determined by the MTT
method) was calculated for the six extracts capable of complete
parasitic growth inhibition at a concentration of 100 g/ml: four
extracts from E. ellipticum and two  from V. macrocarpa (IC50 9.23 to
78.65 g/ml); with no activity observed for S. aureum (Table 1).
Inspired by the clinical use of amphotericin B in the treatment of
fungal infections and leishmaniasis, we selected the V. macrocarpa
root bark EtOAc extract for chemical studies based on its activity,
yield, quantity and polarity. Silica-gel open column chromatogra-
phy of this 8.28 g extract (fungal MIC  0.98–125 g/ml and parasite
IC50 71.47 g/ml) yielded 65 fractions.
Fractionation revealed an unreported compound named herein
as vatacarpan (1), together with musizin (2) (Covell et al., 1961). All
compound structures were established using spectroscopic tech-
niques, including 1D and 2D NMR  analysis, and comparison with
previously reported data.
Compound 1, was a white solid (m.p. 135.2–136.4 ◦C). The
infrared (IR) spectrum showed absorption bands at 3384 cm−1
characteristic of hydroxyl groups and at 1620 and 1570 cm−1 of the
skeletal vibrations of the benzene ring. Asymmetric and symmetric
C O C stretching of aryl-alkyl ether at 1261–1199 and 1085 cm−1,
respectively, were also observed in addition to phenol absorptions
at 1380 and 1165 cm−1. The HRESIMS of 1 displayed a molecular
ion peak at m/z  423.2166 corresponding to the molecular formula
C26H30O5.
In the 1H NMR  spectrum (300 MHz, CDCl3), a methoxy group at
ıH 3.79 (s) and an aromatic proton at ıH 7.26 (H1, s) were observed,
consistent with a pentasubstituted benzene moiety and three aro-
matic protons compatible with the presence of an ABX spin system
at ı 6.34 (H , d, 2.2), 6.36 (H , dd, 7.9, 2.2) and 7.01 (H , d, 7.9).H 10 8 7
The presence of two prenyl groups were suggested from the sig-
nals of the four methyl groups at ıH 1.66 (H5′ , s), 1.76 (H4′ , s),
1.54 (H4′′ , s) and 1.70 (H5′′ , s) and the two  oleﬁnic protons at ıH
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.14 (H2′ , t, J = 6.5 Hz) and 5.23 (H2′′ , t, J = 7.5 Hz), in addition to the
wo methylene protons at ıH 3.34 (H1′ , d, J = 6.5) and 2.45 (H1′′ , d,
 = 7.5). The correlation of these signals in the COSY spectrum con-
rmed the two prenyl moieties. In addition, the 1H NMR  spectrum
evealed signals for a diastereotopic methylene at ıH 4.02 (H6, d,
0.0) and 3.64 (H6, d, J = 10.0 Hz) and an oxymethine proton at ıH
.10 (H11a, s) typical of the oxymethylene and oxymethine protons
f the heterocyclic ring B (2H-6) and C (H-11a) of a 6a-substituted
terocarpan skeleton, respectively. The pterocarpan skeleton was
upported by the correlation displayed between H-6 and H-11a in
he NOESY spectrum.
The 13C and DEPT 135◦ NMR  spectroscopic data of 1 (Table 2)
evealed 26 carbon atoms, corresponding to: four methyls (C 18.1,
8.2, 25.9 and 26.2); a methoxyl (C 61.7); three methylenes (C
0.6, 31.2 and 26.7); one oxymethine (C 83.1); one nonhydro-
enated (C 46.7); four oleﬁnic carbons (ıC 118.9, 122.8, 131.0 and
35.6); four hydrogenated aromatic carbons (C 98.6, 107.7, 114.3
nd 124.4); and eight quaternary aromatic carbons (C 116.0, 123.2,
23.9, 143.7, 146.6, 147.3, 156.8 and 160.9). The 1H, 13C-HSQC spec-
rum exhibited correlation between the hydrogens at H 4.02 (H6,
, 10.0), 3.64 (H6, d, 10.0 Hz) and 5.10 (H11a, s) with the oxycar-
ons at C 70.6 (C-6) and 83.1 (C-11a), respectively. These NMR
ignals together with the methine carbon at C 46.7 (C-6a), ratiﬁed
he presence of a 6a-substituted pterocarpan skeleton.
The deshielding of the methylene hydrogens 2H-1′ (H 3.34)
hen compared with the 2H-1′′ (H 2.45), was associated to
nisotropic effect of the aromatic ring a-located at the C-1′ carbon.
n addition, the HMBC correlation of the 2H-1′ (H 3.34) with the
arbons at C 116.0 (C-4), and 147.3 (C-4a) established the position
he one prenyl fragment at C-4 in the aromatic ring A. Other HMBC
orrelation of the methoxyl protons (s, 3.79) with the signal at C
46.6 (C-3), and concomitant correlation of the H-1 (s, 6.95) with
he signals at C 123.2 (C-1a), 146.6 (C-3), and 83.1 (C-11a), indi-
ated the position of the methoxyl and hydroxyl groups, at C-3 and
-2, respectively, conﬁrmed the substitution pattern in aromatic
ing A. The location of the hydroxyl group at the C-9 carbon of the
risubstituted aromatic ring D was based on HMBC correlation of
he hydrogen at H 7.01 (H-7) to the carbons at C 156.8 (C-10a)
nd 160.9 (C-9) and concomitant correlation of the hydrogens at
H 6.36 (H-8) and 6.34 (H-10) with the carbon at C 123.9 (C-7a),
n accordance with biogenetic backgrounds (Dewick, 2002).
The relative stereochemistry of the B and D pterocarpan rings
as determined by the NOESY experiment, which revealed dipolar
nteractions of the methylene 2H-1′′ with the hydrogens H-6 and
-11a. In addition, the positive optical rotation value []D = + 63◦
c. 0.1, MeOH) was decisive for the assignment of the absolute ste-
eochemistry of the stereogenic centers C-6a and C-11a as S (Araújo
t al., 2008). Thus, compound 1 was identiﬁed as (+)-6aS,11aS-2,9-
ihydroxy-3-methoxy-4,6a-diprenyl-pterocarpan on the basis of
he NMR  (1D and 2D, Table 2) spectral data and HRESIMS (positive
ode).
Pterocarpans, the second largest group of natural isoﬂavonoids,
eceived this name from Pterocarpus species, the ﬁrst source of
his class of compounds. Since then, many structurally diverse pte-
ocarpans have been isolated and some demonstrate interesting
iological activities (Goel et al., 2013). Pterocarpans have been
ainly found in a large number of Fabaceae species, and have been
eported to exhibit antifungal (Jiménez-González et al., 2008) and
ntiprotozoal (Vieira et al., 2008) activities.
Compound 2 was obtained as brown crystals. The IR spectrum
howed absorption bands of O H stretching at 3297 cm−1 and car-
onyl conjugated C O stretching at 1628 cm−1. Phenol absorptions
ere also observed at 1378–1317 cm−1 and 1280–1160 associ-
ted to C O stretching, and at 1580 and 1440 cm−1 of the skeletal
ibrations of the aromatic ring. The NMR  spectra (see Suppor-
ing information) showed the presence of two methyl groups, anarmacognosia 25 (2015) 401–406
chelatogenic hydroxyl group, a carbonyl group, and a naphthalene
ring. Following analysis by spectroscopic means and comparison
with the data from the literature, compound 2 was identiﬁed as
musizin (Covell et al., 1961) otherwise named dianellidin (Dias
et al., 2009) and nepodin (Li and McLaughlin, 1989).
The literature describes the activity of musizin against C. albicans
ATCC 14053 and Trichophyton mentagrophytes ATCC 28185 (Dias
et al., 2009), and as a potent antiprotozoal compound against
malaria parasites (Lee and Rhee, 2013).
Vatacarpan (1) was active against C. albicans ATCC 10231 with
a MIC  value (MIC 0.98 g/ml) comparable to ﬂuconazole (MIC
1.00 g/ml) and superior to amphotericin B (MIC 4.00 g/ml).
The literature reports the production of pterocarpans as a
response to biotic and abiotic factors, such as fungal and other
pathogen challenges (Jiménez-González et al., 2008; Goel et al.,
2013). Pterocarpans accumulate in infected tissue, the site of anti-
fungal activity. For some of them high concentrations are reached
rapidly, then slowly decrease as the infection ceases (Jiménez-
González et al., 2008). Several studies have tried to relate the
structure of the pterocarpan system with their fungicidal activity.
Investigations have shown that the roots of some plants
which contain pterocarpans have a strong activity toward human
pathogens (Jiménez-González et al., 2008). It is well established
that lipophilic pterocarpans possess increased antifungal activity,
since they cross fungal membranes more easily (Harborne, 1978).
The root bark is the source of the V. macrocarpa extract studied. This
organ is continuously challenged to soil microorganisms, humidity
and oxidative stress, conditions that may  enhance the production
of pterocarpans.
Biological activity screening of V. macrocarpa extracts demon-
strated the most positive results in terms of activity spectrum.
The two  extracts active against the protozoa were from the root
(Table 1). All of the V. macrocarpa extracts were active against at
least one fungal strain (MIC ≤125 g/ml) (Table 1), with the major-
ity of MIC  values for C. parapsilosis ATCC 22019 comparable to, or
better than, the drug controls. C. parapsilosis is regarded as refer-
ence yeast (CLSI, 2008a,b, 2012). A decade-spanning multi-centric
study in Brazilian hospitals revealed an increase in the incidence of
Candida non-albicans pathogens, primarily C. parapsilosis (Colombo
et al., 2006). Another study in 29 Spanish hospitals reported can-
didemia in ICU patients caused by non-albicans species in 48%
of cases, with C. parapsilosis as the most common species (Puig-
Asensio et al., 2014). In dermatophytes, the MIC  values ranged
from 31.25 to 125 g/ml (Table 1). Literature reports the traditional
use of V. macrocarpa root and stem bark in superﬁcial mycoses
treatment in Amazonia (Piedade and Filho, 1988). In this work,
the ethyl acetate extracts from the same plant organs were active
against clinical isolates of Trichophyton mentagrophytes LMGO 09
and T. rubrum LMGO 06 (MIC 31.25 to ≤125 g/ml) – the dermato-
phytes responsible for the majority of superﬁcial fungal infections
in the Americas (Grannoum et al., 2013; Havlickova et al., 2008).
V. macrocarpa remains a widely used treatment of diabetes melli-
tus symptoms (Baviloni et al., 2010; Oliveira et al., 2008), or as an
antiulcer and anti-inﬂammatory (Jesus et al., 2009) – suggesting
that it is a non-toxic species, as shown in experimental animals for
heartwood methanol extract (Jesus et al., 2012).
V. macrocarpa and V. guianensis are often described in the lit-
erature as sources of lectins, a very diverse class of proteins.
Lectins found in the seeds of these species, among other Fabaceae,
show various biological activities, such as alternative antimicrobial
agents (Vasconcelos et al., 2014), as histological markers, or as tools
for cancer research (Sousa et al., 2015).Interesting observations for E. ellipticum were (1) only the ethyl
acetate extracts demonstrated activity against C. parapsilosis ATCC
22019 (MIC 3.91 to 125 g/ml); (2) this plant species provided the
highest number of anti-Leishmania extracts; and (3) its stem bark
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thyl acetate extract demonstrated the most leishmanicidal activ-
ty (IC50 9.23 g/ml) (Table 1). This species is locally known as
brincos-de-saguim” because its fruit resembles “monkey’s ears”
nd it is used by traditional communities to treat pulmonary infec-
ions (Corrêa, 1984). Other species of the same genus are used in
razil to treat parasitism and gonorrhea (Mimaki et al., 2004).
S. aureum extracts were inactive against L. (L.) amazonensis, but
xhibited high activity in 71% of the tests conducted against ATCC
trains and clinical isolates of pathogenic fungi. C. glabrata LMGO
4 results (MIC 0.12 to 31.25 g/ml) (Table 1) are therefore an
mportant consideration in the search for leader compounds given
he increased clinical incidence of this species (Puig-Asensio et al.,
014). It is important to note that S. aureum is used by the Cerrado
ommunities for the treatment of fungal infections and as a hep-
toprotector – suggesting that it is a non-toxic species. Quilombola
nd some indigenous Brazilian people use a decoction of the stem
ark as a contraceptive (Rodrigues, 2007). The Mumbuca commu-
ity use a S. aureum infusion as a hepatoprotector in Tocantins State,
razil (Coelho et al., 2005). Another Sclerolobium species is used in
he treatment of skin diseases (Mun˜oz et al., 2000).
Previous results from the Cerrado plant extract library, built by
ur research group, have demonstrated that root and stem extracts,
ainly from bark are often active against fungi and protozoa (Da
osta et al., 2014). These pathogen exposed plant organs should be
rioritized for target compounds isolation.
Antifungal (85%) and leishmanicidal (23%) activity were
bserved for 26 extracts from three species of the Fabaceae fam-
ly. E. ellipticum was distinguished by its activity against L. (L.)
mazonensis, especially the stem bark ethyl acetate extract (IC50
.23 g/ml). S. aureum presented no activity against the parasite,
ut curiously six root/stem wood and root/stem ethyl acetate or
thanol extracts exhibited differential antifungal activity (MIC 0.12
o 31.25 g/ml). V. macrocarpa extracts were also active against
oth micro-organisms. Its root and stem bark are used in super-
cial mycoses treatment in Amazonia–traditionally referred to as
ngelim-do-cerrado or maleiteira (Piedade and Filho, 1988). The
esults found in Trichophyton models are consistent with this tra-
itional use.
Fractionation of V. macrocarpa root bark EtOAc extract resulted
n the isolation of a previously unreported vatacarpan (1) and
nown compound musizin (2). Vatacarpan demonstrated notable
ctivity against C. albicans ATCC 10231 (MIC 0.98 g/ml), an oppor-
unistic pathogenic fungi which is the main etiological agent of
andidiasis (Pierce and Lopez-Ribot, 2013).
This work documents the activity of Cerrado plant extracts
gainst resistant clinical fungal isolates and Leishmania. Further-
ore, it conﬁrms the need to conserve the Cerrado biome hotspot
ith the view to developing lead molecules (Da Costa et al., 2014).
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